Drug Trial Radar · NCT06708260
A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects With DME
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Dec 12, 2024
Primary completion
Aug 12, 2026
Study completion Aug 20, 2026
Sponsor
- Lead sponsor
- EnnovaBioIndustry
- Sponsor type
- Industry
- First posted
- Nov 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, parallel study to evaluate the efficacy and safety of two doses of ENN0403 in subjects with diabetic macular edema (DME). Approximately 60 subjects will be randomized to receive ENN0403 capsule orally once a day at the low dose or high dose with a 1:1 ratio. The study period consisted of up to 2 weeks of screening, 12 weeks of treatment and 2 weeks of follow-up, and the entire trial period was up to 16 weeks.
Conditions
- Diabetic Macular Edema (DME)
Interventions
ENN0403, low doseDrug
ENN0403 capsules will be orally administered once a day for 12 weeks.
ENN0403, high doseDrug
ENN0403 capsules will be orally administered once a day for 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Central Retinal Thickness (CRT) at week 12Time frame: week 12
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Shijiazhuang People's Hospital
Shijiazhuang, Hebei, China
Hebei Eye Hospital
Xingtai, Hebei, China
Zhengzhou Second Hospital
Zhengzhou, Henan, China
Affiliated Hospital of Shandong Second Medical University
Weifang, Shandong, China
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China
Shanxi Eye Hospital
Taiyuan, Shanxi, China
Xian No.1 Hospital
Xi’an, Shanxi, China
Hospital of Chengdu University of TCM
Chengdu, Sichuan, China
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.